|
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) (USD $)
In Thousands, except Share data, unless otherwise specified |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
|
Jun. 30, 2012
|
Jun. 30, 2011
|
Jun. 30, 2012
|
Jun. 30, 2011
|
|
| Revenues | ||||
| Contract revenue | $ 2,270 | $ 2,140 | $ 4,733 | $ 4,641 |
| Grant revenue | 387 | 295 | 671 | 784 |
| Total revenues | 2,657 | 2,435 | 5,404 | 5,425 |
| Costs and expenses | ||||
| Research and development | 5,027 | 4,444 | 10,596 | 9,032 |
| General and administrative | 1,162 | 1,392 | 2,421 | 2,611 |
| Depreciation | 80 | 67 | 155 | 127 |
| Total costs and expenses | 6,269 | 5,903 | 13,172 | 11,770 |
| Loss from operations | (3,612) | (3,468) | (7,768) | (6,345) |
| Interest income | 12 | 33 | 15 | 66 |
| Other (expense) income, net | (113) | 212 | (296) | (874) |
| Net loss | (3,713) | (3,223) | (8,049) | (7,153) |
| Basic and diluted net loss per share | $ (0.13) | $ (0.14) | $ (0.29) | $ (0.32) |
| Weighted average shares outstanding, basic and diluted | 29,405,986 | 23,502,581 | 27,476,603 | 22,693,155 |
| Items included in other comprehensive income (loss): | ||||
| Proportional share of comprehensive (loss) income of equity-method investment | 19 | (28) | 31 | |
| Unrealized gain on available-for-sale securities | 19 | 40 | ||
| Other comprehensive income (loss) items | 38 | (28) | 71 | |
| Comprehensive loss | $ (3,713) | $ (3,185) | $ (8,077) | $ (7,082) |